thiophenes has been researched along with Behavior Disorders in 10 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (10.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 3 (30.00) | 29.6817 |
2010's | 6 (60.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
He, Y; Wang, HT; Wang, L; Yu, G | 1 |
Bitter, I; Corponi, F; Fabbri, C; Kasper, S; Montgomery, S; Pallanti, S; Serretti, A; Vieta, E | 1 |
Corrigan, PW; Fokuo, JK; Kosyluk, KA; Park, JH | 1 |
Allen, RP | 1 |
Kibble, A | 1 |
Citrome, L; Maeda, K; Stensbøl, TB | 1 |
RIESE, JA | 1 |
Kranzler, J; Nemeroff, CB; Owens, MJ; Plott, SJ; Rao, SG; Vaishnavi, SN | 1 |
Borges-Gonzalez, S; Flockhart, D; Preskorn, SH | 1 |
Aubry, JM; Barbe, R; Bertschy, G; Bryois, C; Delini-Stula, A; Gervasoni, N; Merlo, M | 1 |
6 review(s) available for thiophenes and Behavior Disorders
Article | Year |
---|---|
Rotigotine transdermal patch for the treatment of neuropsychiatric symptoms in Parkinson's disease: A meta-analysis of randomized placebo-controlled trials.
Topics: Dopamine Agonists; Humans; Mental Disorders; Parkinson Disease; Psychotropic Drugs; Randomized Controlled Trials as Topic; Tetrahydronaphthalenes; Thiophenes; Transdermal Patch | 2018 |
Novel antipsychotics specificity profile: A clinically oriented review of lurasidone, brexpiprazole, cariprazine and lumateperone.
Topics: Animals; Antipsychotic Agents; Heterocyclic Compounds, 4 or More Rings; Humans; Lurasidone Hydrochloride; Mental Disorders; Piperazines; Quinolones; Thiophenes | 2019 |
Restless legs syndrome/Willis Ekbom disease: evaluation and treatment.
Topics: Diagnosis, Differential; Dopamine Agonists; Humans; Mental Disorders; Restless Legs Syndrome; Tetrahydronaphthalenes; Thiophenes | 2014 |
The preclinical profile of brexpiprazole: what is its clinical relevance for the treatment of psychiatric disorders?
Topics: Animals; Clinical Trials, Phase III as Topic; Drug Evaluation, Preclinical; Humans; Mental Disorders; Quinolones; Randomized Controlled Trials as Topic; Thiophenes | 2015 |
Clinically relevant pharmacology of neuropsychiatric drugs approved over the last three years: Part II.
Topics: Anti-HIV Agents; Antidepressive Agents; Antiparkinson Agents; Apomorphine; Atazanavir Sulfate; Azabicyclo Compounds; Carbamates; Central Nervous System Agents; Cytochrome P-450 Enzyme System; Drug Approval; Drug Interactions; Duloxetine Hydrochloride; Furans; Humans; Hypnotics and Sedatives; Indenes; Long QT Syndrome; Mental Disorders; Oligopeptides; Organophosphates; Piperazines; Psychopharmacology; Pyridines; Sulfonamides; Thiophenes | 2006 |
[Psychiatry].
Topics: Adolescent; Antidepressive Agents; Bipolar Disorder; Child; Depression; Duloxetine Hydrochloride; Humans; Mental Disorders; Schizophrenia; Thiophenes | 2007 |
1 trial(s) available for thiophenes and Behavior Disorders
Article | Year |
---|---|
How does direct to consumer advertising affect the stigma of mental illness?
Topics: Adult; Advertising; Attitude to Health; Depression; Duloxetine Hydrochloride; Female; Humans; Male; Mental Disorders; Psychotropic Drugs; Stereotyping; Surveys and Questionnaires; Thiophenes | 2014 |
3 other study(ies) available for thiophenes and Behavior Disorders
Article | Year |
---|---|
American Psychiatric Association - 168th Annual Meeting (May 16-20, 2015 - Toronto, Canada).
Topics: Alcoholism; Benzofurans; Canada; Drug Discovery; Humans; Indoles; Mental Disorders; Piperazines; Psychiatry; Quinolones; Schizophrenia; Thiophenes; Vilazodone Hydrochloride | 2015 |
FUNCTIONAL GASTROINTESTINAL DISEASE.
Topics: Cyclohexanes; Drug Therapy; Fluphenazine; Gastrointestinal Diseases; Humans; Mental Disorders; Psychosomatic Medicine; Psychotherapy; Stress, Physiological; Thiophenes | 1965 |
Milnacipran: a comparative analysis of human monoamine uptake and transporter binding affinity.
Topics: Adrenergic Uptake Inhibitors; Antidepressive Agents; Carrier Proteins; Citalopram; Cyclohexanols; Cyclopropanes; Duloxetine Hydrochloride; Humans; Membrane Glycoproteins; Membrane Transport Proteins; Mental Disorders; Milnacipran; Nerve Tissue Proteins; Neurons; Norepinephrine; Norepinephrine Plasma Membrane Transport Proteins; Selective Serotonin Reuptake Inhibitors; Serotonin; Serotonin Plasma Membrane Transport Proteins; Symporters; Thiophenes; Venlafaxine Hydrochloride | 2004 |